Ciscovery Bio

Ciscovery Bio is a private Philadelphia-based non-coding genomics company focused on discovering cis-regulatory modules in the non-coding genome and applying them to drug development, gene therapy, and precision medicine. The company positions its technology as a platform for identifying non-coding biomarkers, profiling drug-induced cellular changes, and enabling more precise control of therapeutic gene expression. Ciscovery Bio appears to operate primarily as a tools and platform company rather than as a late-stage therapeutics developer. Publicly available information indicates an early-stage, venture-backed business with roots as a Rutgers University spinout. Its disclosed work includes intellectual property around targeting aberrant cells through modulation of cis-regulatory modules.